MiR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression

Biochemical and Biophysical Research Communications

Volumn 444, Issue 2, 2014, Pages 230-234

  Gao, Yong ^a   Luo, Ling Hui ^a   Li, Shuai ^a   Yang, Cao ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Invasion; Migration; miR 17; Osteosarcoma; Proliferation; PTEN

Indexed keywords

INVASION; MIGRATION; MIR-17; OSTEOSARCOMA; PROLIFERATION; PTEN;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; MICRORNAS; NEOPLASM METASTASIS; OSTEOSARCOMA; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR BURDEN;

EID: 84894594665     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.061     Document Type: Article

References (23)

1. L. Mirabello, R.J. Troisi, and S.A. Savage Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program Cancer 115 2009 1531 1543
2. K. Yan, J. Gao, T. Yang, Q. Ma, X. Qiu, Q. Fan, and B. Ma MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo PLoS ONE 7 2012 e33778
3. E.K. Amankwah, A.P. Conley, and D.R. Reed Epidemiology and therapies for metastatic sarcoma Clin. Epidemiol. 5 2013 147 162
4. N. Rainusso, L.L. Wang, and J.T. Yustein The adolescent and young adult with cancer: state of the art - bone tumors Curr. Oncol. Rep. 15 2013 296 307
5. Z. Wang, H. Cai, L. Lin, M. Tang, and H. Cai Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma Pediatr. Blood Cancer 61 2 2014 206 210 10.1002/pbc.24763 Epub 2013 Sep 9
6. Z. Wu, X. Huang, X. Huang, Q. Zou, and Y. Guo The inhibitory role of Mir-29 in growth of breast cancer cells J. Exp. Clin. Cancer Res. 32 2013 98
7. L. Geng, A. Chaudhuri, G. Talmon, J.L. Wisecarver, C. Are, M. Brattain, and J. Wang MicroRNA-192 suppresses liver metastasis of colon cancer Oncogene 2013 10.1038/onc.2013.478 [Epub ahead of print]
8. W. Li, F. Guo, P. Wang, S. Hong, and C. Zhang MiR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status Curr. Mol. Med. 14 1 2014 185 195
9. W. Nian, X. Ao, Y. Wu, Y. Huang, J. Shao, Y. Wang, Z. Chen, F. Chen, and D. Wang MiR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2 Oncol. Lett. 6 2013 359 366
10. Y. Wang, W. Zhao, and Q. Fu MiR-335 suppresses migration and invasion by targeting ROCK1 in osteosarcoma cells Mol. Cell. Biochem. 384 2013 105 111
11. H. Li, C. Bian, L. Liao, J. Li, and R.C. Zhao MiR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1 Breast Cancer Res. Treat. 126 2011 565 575
12. Y. Ma, P. Zhang, F. Wang, H. Zhang, Y. Yang, C. Shi, Y. Xia, J. Peng, W. Liu, Z. Yang, and H. Qin Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130 Nat. Commun. 3 2012 1291
13. S. Lu, S. Wang, S. Geng, S. Ma, Z. Liang, and B. Jiao Increased expression of microRNA-17 predicts poor prognosis in human glioma J. Biomed. Biotechnol. 2012 2012 970761
14. H.M. Namlos, L.A. Meza-Zepeda, T. Baroy, I.H. Ostensen, S.H. Kresse, M.L. Kuijjer, M. Serra, H. Burger, A.M. Cleton-Jansen, and O. Myklebost Modulation of the osteosarcoma expression phenotype by microRNAs PLoS ONE 7 2012 e48086
15. S.W. Shan, L. Fang, T. Shatseva, Z.J. Rutnam, X. Yang, W. Du, W.Y. Lu, J.W. Xuan, Z. Deng, and B.B. Yang Mature miR-17-5p and passenger miR-17-3p induce hepatocellular carcinoma by targeting PTEN, GalNT7 and vimentin in different signal pathways J. Cell Sci. 126 2013 1517 1530
16. J. Zheng, P. Dong, S. Gao, N. Wang, and F. Yu High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma Hepatogastroenterology 60 2013 549 552
17. H.J. Yan, W.S. Liu, W.H. Sun, J. Wu, M. Ji, Q. Wang, X. Zheng, J.T. Jiang, and C.P. Wu MiR-17-5p inhibitor enhances chemosensitivity to gemcitabine via upregulating Bim expression in pancreatic cancer cells Dig. Dis. Sci. 57 2012 3160 3167
18. H. Li, and B.B. Yang Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2 Oncotarget 3 2012 1653 1668
19. D. Li, Y. Zhang, Y. Xie, J. Xiang, Y. Zhu, and J. Yang Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer Cancer Gene Ther. 20 2013 251 259
20. N.R. Leslie, I.H. Batty, H. Maccario, L. Davidson, and C.P. Downes Understanding PTEN regulation: PIP2, polarity and protein stability Oncogene 27 2008 5464 5476
21. R.C. Castellino, and D.L. Durden Mechanisms of disease: the PI3K-Akt-PTEN signaling node - an intercept point for the control of angiogenesis in brain tumors Nat. Clin. Pract. Neurol. 3 2007 682 693
22. G. Zhang, H. Zhou, H. Xiao, Z. Liu, H. Tian, and T. Zhou MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN Dig. Dis. Sci. 59 1 2014 98 107 10.1007/s10620-013-2858-8 Epub 2013 Sep 12
23. S. Phin, M.W. Moore, and P.D. Cotter Genomic rearrangements of in prostate cancer Front. Oncol. 3 2013 240